SYNGENE Career Opportunities: Formulation Development
Scientist Parenteral/Injectables
Job Title Formulation Development Scientist-
Parenteral/Injectables
Position Sr.Research Associate
Required Educational Qualification M.Pharma
Required work experience 1-2 years
Job Location Bangalore
Required Skill sets
- Hands on experience with injectable dosage forms is a
must.
- Complex injectables a plus
Job Purpose Responsible for pre-formulation and formulation
development, stability studies, scale-up and tech transfer of drug product
based on the scope of projects.
Job Description-Primary Job Responsibilities Documentation
Ensure appropriate documentation for projects as per Syngene
policy.
Compilation and interpretation of results and report writing
Manage laboratory notebook for all concerned projects.
Compile and manage data and write protocols, reports as required.
Project Planning- Oral solid Dosage forms
Ensure proper planning and availability of resources for
seamless execution of projects
Manage project related supplies of API, raw materials,
packaging components as required
Project Execution- Oral solid Dosage forms
Conduct literature search for research purposes
Execute projects related to pre-formulation, formulation and
process development, scale up, Technology transfer and cGMP manufacturing of
clinical supplies.
Plan and execute stability studies
Ensure seamless execution of projects as per committed
timelines.
Troubleshooting and problem solving for challenges within
projects
Interact with cross functional teams (chemistry, analytical
etc.) for execution of projects.
Effectively co-ordinate between teams for cross functional
activities
Quality Compliance Compliance and Adherence to all Syngene
quality systems
EHSS Compliance Compliance to Syngene EHSS policies and
systems
Secondary Job Responsibilities Support for preparation of
SOPs, ECCs (Equipment Clearing Checklist), EOPs, IOPs Provide on the job
training to operators and casuals Support for
client visits and audits.
TO APPLY CLICK HERE
FOR MORE JOB UPDATES
No comments:
Post a Comment